The ability to directly measure acetylcholine (ACh) release is an essential first step towards understanding its physiological function. Here we optimized the GRABACh (GPCR-Activation-Based-ACh) sensor with significantly improved sensitivity and minimal downstream coupling. Using this sensor, we measured in-vivo cholinergic activity in both Drosophila and mice, revealing compartmental ACh signals in fly olfactory center and single-trial ACh dynamics in multiple regions of the mice brain under a variety of different behaviors 2 / 37 Cholinergic signals mediated by the neurotransmitter ACh are involved in a wide range of physiological processes, including muscle contraction, cardiovascular function, neural plasticity, attention and memory 1-3 .
3 / 37 fluorescence change, even at high ACh concentrations (e.g. 100 μM) (Figs. 1B-D and S1F). Importantly, ACh3.0 shared a similar affinity for ACh as ACh2.0 (EC50~2 μM) and did not respond to other major neurotransmitters ( Fig. 1E, F) . Moreover, the ACh-induced response in ACh3.0 could be blocked by the muscarinic receptor antagonist tiotropium (Tio) (Fig. 1F ). Using multiple assays including intracellular Ca 2+ imaging, a Gq-dependent luciferase complementary assay 9 , and a β-arrestin-dependent TANGO assay 10 , we confirmed that ACh3.0 has virtually no coupling with major GPCR-mediated downstream pathways (Figs. 1G,H and S3A-E).
We previously reported that the ACh2.0 sensor could be used to record endogenous ACh release, including the GABABR-dependent potentiation of ACh release in the MHb-IPN (medial habenula-interpeduncular nucleus) projection in acute mouse brain slices 7, 11 . We next tested whether ACh3.0 had better performance in reporting endogenous ACh in MHb-IPN slices. Consistent with our in vitro results, the ACh3.0 sensor has a significantly larger fluorescence increase compared to ACh2.0 in response to high-frequency (>10 Hz) electrical stimulation of the cholinergic fibers, both in control ACSF solution and in the presence of the GABABR agonist baclofen (Bac) (Figs. 2B, C and S4A-F). Application of the GABABR antagonist saclofen (Sac) reversed the baclofen-induced potentiation, and further adding Tio eliminated the stimulation-evoked response (Fig. 2D) . Moreover, the electrical stimulation-evoked signal was increased by the potassium channel blocker 4-AP and eliminated by Cd 2+ , consistent with Ca 2+ -dependent ACh release (Figs. 2E and S4G, H). Using a brief (100-ms) electrical stimulation, we then measured the kinetics of the fluorescence response, yielding tauon and tauoff values of ~105 ms and 3.7 s, respectively (Fig. 2F ).
Next, we used in vivo two-photon imaging to compare the performance of ACh3.0 and ACh2.0 in transgenic Drosophila expressing the ACh sensors in Kenyon cells (KCs) of the olfactory mushroom body (Fig. 2G ).
Physiologically relevant stimuli, including body shock to the abdomen and odor stimulation, elicited only a minor fluorescence signal in the horizontal lobe of the mushroom body in ACh2.0-expressing flies. In contrast, the same 4 / 37 stimuli induced a significantly larger response in ACh3.0-expressing flies, and such increase was higher in γ3 lob compared with adjacent γ2 lobe, which revealed compartment-specific release of ACh (Fig. 2G, H) . In addition, we monitored ACh dynamics in response to direct neuronal activation of KCs via CsChrimson-mediated optogenetics 12 or electrical stimulation. A single 635-nm laser pulse evoked a clear increase in ACh3.0 fluorescence, and multiple pulses applied at 10-Hz induced a progressively larger response that was largely eliminated by Tio application (Fig. 2I, J) . Electrical stimulation of KCs confirmed the frequency-dependent fluorescence increase in the ACh3.0 sensor, with rapid kinetics (tauon ~0.09 s and tau0ff ~0.91 s) ( Fig. S5 ). Taken together, these data show that the ACh3.0 sensor can reliably detect ACh release with high sensitivity and spatialtemporal resolution.
Cholinergic signaling plays a key role in modulating a variety of physiological processes, including plasticity and arousal. We therefore examined whether ACh3.0 can be used in vivo to monitor ACh release in behaving mice. In the mouse brain, basal forebrain cholinergic neurons project to the amygdala, hippocampus and cortical regions 13 .
We measured foot-shock evoked cholinergic signal in the basolateral amygdala (BLA), which is believed to be important in aversive associate learning 14 . A brief foot-shock stimulus induced a reproducible and time-locked increase in ACh3.0 fluorescence (Fig. 3A, B ). We then combined pharmacology and genetics to confirm the signal's specificity. Treating the mice with the acetylcholinesterase inhibitor (AChEI) donepezil (Done) significantly slowed the fluorescence decay, while the M3R antagonist scopolamine (Scop) abolished the foot-shock-induced fluorescence response. As a control, no response was observed in mice expressing ACh3.0-mut ( Fig. 3D ) or in mice lacking the vesicular ACh transporter (VAChT) 15 , suggesting the synaptic origin of ACh release (Figs. 3E and S6A-C). Taken together, these in vivo data indicates that the ACh3.0 sensor can reliably report foot-shock induced cholinergic signaling in the BLA. Next, we examined whether ACh3.0 could stably report ACh signaling over a longer time period by recording ACh dynamics in the mouse hippocampus during the sleep-wake cycle. A simultaneous recording of EEG and EMG was used to monitor the animal's sleep status ( Fig. 3F , see Methods for 5 / 37 detail). We found that the average fluorescence signal was larger in wakefulness and REM sleep, but lower during non-REM sleep (Figs. 3G, H), consistent with our previous optrode-based recordings of the firing rate of basal forebrain cholinergic neurons 16 . Interestingly, ACh3.0 was also able to detect ACh increase induced by microarousal events during NREM sleep ( Fig. 3G ). Overall, these data illustrate that the ACh3.0 has both the high sensitivity, rapid kinetics and stability needed to reliably track long-term physiological cholinergic signal in vivo.
Next, to demonstrate that the applicability of using the ACh3.0 sensor in tracking cholinergic signaling with high spatial resolution in freely behaving animals, we measured cortical ACh signals in response to different stimuli using miniature two-photon microscopy 17 . We expressed the ACh3.0 sensor in the mouse visual cortex and monitored the fluorescence signal using a miniature two-photon microscope attached to the head of the mouse ( Fig. 3I ). During two-photon imaging, we placed the mouse on a treadmill and measured the ACh3.0 signal in response to auditory or visual stimuli or during animal's locomotion. We observed a robust increase in ACh3.0 fluorescence when the mouse was running, but not during the application of sensory stimulation (Fig. 3J ). We could also reveal spatial selective ACh signals at certain time points during running from a single imaging trial, indicating the ACh3.0 has high spatial and temporal resolution to resolve ACh patterns ( Fig. 3K ). Moreover, the fluorescence response positively correlated with the running speed of the mice (Fig. 3L ). The running-related increase in the ACh3.0 signal was abolished by M3R antagonist Scop, but not nAChR blocker mecamylamine (Meca), indicating a high specificity of the measured fluorescence signal (Fig. 3M ).
Our previous ACh2.0 sensor has been reported to couple with downstream Gq signaling, although with ~10 fold less affinity compared with native M3R. In contrast, the optimized ACh3.0 sensor has negligible coupling to G protein signaling in two independent assays (Figs. 1G and S3D). We reasoned that these improvements might be due to truncation of the receptor's ICL3 domain, which prevents the receptor from interacting with the G protein and β-arrestin. Thus, the ACh3.0 sensor can be viewed as a highly sensitive ACh detector that functions 6 / 37 independently from cellular signaling. Indeed, we confirmed that expressing ACh3.0 does not affect the physiological properties of neurons, as odorant-evoked Ca 2+ transients in Drosophila expressing both ACh3.0 and jRCaMP1a were similar to those in flies expressing only jRCaMP1a ( Fig. S3F , G).
In conclusion, we engineered the GRABACh3.0 with higher sensitivity while maintained its specificity, precise temporal and spatial resolution and high photo-stability in detecting ACh. The new sensor provides a robust tool for testing previously suggested hypotheses on the dynamics of cholinergic activity under both physiological and pathophysiological conditions. With respect to studying physiological processes, the ACh3.0 sensor allows the real-time visualization of compartment-specific ACh release in the Drosophila olfactory system and cholinergic dynamics during the sleep-wake cycle in mice, shedding new light on how cholinergic signaling is regulated. The combination of improved ACh sensor with advanced imaging techniques will help to address fundamental biological questions in the future.
Methods
Animals. Male and female P0 Sprague-Dawley rats were used to prepare cultured cortical neurons; P28-48 wild-type C57BL/6N mice were used to prepare the acute brain slices and two-photon in vivo imaging. C57BL/6J mice were used for fiber photometry recording. Mice lacking the vesicular acetylcholine transporter in the forebrain were generated as previously described 18 by crossing VAChT flox/flox mice (Chat/Slc18a3 tm1.2Vpra generated in a mixed C57BL/6J × 129/ SvEv background, backcrossed to C57BL/6J for 10 generations) 15 Molecular biology. Plasmids were generated using the Gibson assembly method 19 . DNA fragments were generated using PCR amplification using primers (Thermo Fisher Scientific) with 30-bp overlap. The fragments were then assembled using T5exonuclease (New England Biolabs), Phusion DNA polymerase (Thermo Fisher Scientific), and Taq ligase (iCloning). All sequences were verified using Sanger sequencing at the Sequencing Platform in the School of Life Sciences of Peking University.
For screening in HEK293T cells, the ACh sensor constructs were cloned in the pDisplay vector (Invitrogen) followed by the IRES-mCherry-CAAX sequence, which served as a membrane marker to calibrate the signal intensity. Site-directed mutagenesis of the linker sequences and residues in cpEGFP was performed using primers containing randomized NNB codons (48 codons in total, encoding all 20 amino acids; Thermo Fisher Scientific). For AAV package, the ACh3.0 sensor and mutant ACh3.0-mut sensor were cloned into an AAV vector under the control of the human synapsin promoter. To generate transgenic Drosophila lines, the ACh3.0 sensor was cloned into the pJFRC28 vector, which was then used to generate transgenic flies via PhiC31-mediated site-directed integration into attp40.
Cell culture, transfection, and imaging. HEK293T cells (ATCC cell line CRL-3216) were cultured at 37°C in 5% CO2 in DMEM (GIBCO) supplemented with 10% (v/v) fetal bovine serum (GIBCO) and 1% penicillin-streptomycin (GIBCO). HEK293 cells stably expressing a tTA-dependent luciferase reporter and a β-arrestin2-TEV fusion construct were a gift from Bryan L. Roth. Rat cortical neurons were prepared from P0 Sprague-Dawley rat pups (both male and female; Beijing Vital River). In brief, the brains 8 / 37
were dissected, and cortical neurons were dissociated in 0.25% Trypsin-EDTA (GIBCO), plated on 12-mm glass coverslips coated with poly-D-lysine (Sigma-Aldrich), and cultured at 37°C in 5% CO2 in neurobasal medium containing 2% B-27 supplement, 1% GlutaMax, and 1% penicillin-streptomycin (all from GIBCO). HEK293T cells were transfected using the polyethylenimine (PEI) method (with a typical ratio of 1 µg DNA to 4 µg PEI); the media was replaced 4-6 h later, and cells were imaged 24 h after transfection.
Cultured neurons were transfected at 7-9 days in vitro using the calcium phosphate transfection method, and experiments were performed 48 h after transfection. For screening candidate sensors, cultured HEK293T cells expressing the various candidate sensors were first imaged using the Opera Phenix High-Content Screening System (PerkinElmer) equipped with a 60 × /1.15 NA waterimmersion objective, a 488-nm laser, and a 561-nm laser; the ACh sensor's signal was obtained using a 525/50-nm emission filter, and the mCherry-CAAX signal was obtained using a 600/30-nm emission filter. The ratio between green (G) and red (R) fluorescence was calculated before and after application of 100 μM ACh, and the change in the G/R ratio was used as the fluorescence response; the peak G/R ratio was used as a brightness index. Candidate sensors with the best performance were subsequently imaged using a Ti-E A1 inverted confocal microscope (Nikon) equipped with a 40 × /1.35 NA oil immersion objective, a 488-nm laser, and a 561nm laser. Drugs were prepared in Tyrode's solution containing (in mM): 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose (pH 7.4) and perfused into the imaging chamber. The ACh sensor's signal was obtained using a 525/50-nm emission filter, and the mCherry signal was obtained using a 595/50-nm emission filter. Cultured neurons expressing the ACh sensor were similarly imaged using the inverted confocal microscope with drugs added by perfusion.
Slice preparation and imaging. Adeno-associated viruses (AAVs) expressing either ACh2.0 or ACh3.0 were packaged by Vigene Biosciences, and were injected into the mouse interpeduncular nucleus (IPN) (500 nl per mice, titer: 1x10^13 vg/ml). Two weeks after virus injection, the animals were anesthetized with an i.p. injection of Avertin (250 mg/kg body weight), and the heart was perfused with 5ml slicing buffer containing (in mM): 110 choline-Cl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 7 MgCl2, 25 glucose, and 2 CaCl2. The mice were then decapitated and brains were removed immediately and placed directly in cold oxygenated slicing buffer. The brains were first blocked at an ~45° angle relative to the horizontal plane and then sectioned into 250-μm thick slices 9 / 37 using a VT1200 vibratome (Leica); the sections were transferred to oxygenated Ringer's buffer containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 1.3 MgCl2, 25 glucose, and 2 CaCl2. The slices were then recovered at 34°C for at least 40 min.
For two-photon fluorescence imaging, slices were transferred to an imaging chamber and placed in an FV1000MPE two-photon microscope (Olympus) equipped with a 40 × /0.80 NA water-immersion objective and a mode-locked Mai Tai Ti:Sapphire laser (Spectra-Physics) tuned to 920 nm for excitation and a 495∼540-nm filter for signal collection. For electrical stimulation, a bipolar electrode (cat#WE30031.0A3, MicroProbes) was positioned near the IPN region under the fluorescence guidance, and the imaging and stimulation were synchronized using an Arduino board with a custom program. The stimulation voltage was set at ~4 V, and the duration of each stimulation pulse was set at 1 ms. Drugs were added by perfusion or were bath-applied.
Two-photon imaging in Drosophila.
Female Drosophila melanogaster within 3 weeks after eclosion were used for imaging experiments. The fly was mounted on a customized chamber by tape, in a way the antenna and abdomen exposed to the air. The cuticle between compound eyes, as well as air sacs and fat bodies were removed to expose the brain which was then bathed in the saline, i.e. adult hemolymph-like solution (AHLS): (in mM) 108 NaCl, 5 KCl, 5 HEPES, 5 Trehalose, 5 sucrose, 26 NaHCO 3 , 1 NaH 2 PO 4 , 2 CaCl 2 and 2 MgCl 2 . The same Olympus two-photon microscope as well as electrical stimulation equipment used for brain slices imaging was also used here. 920 nm laser was used for excitation. 495~540 nm filter was used for ACh2.0 or ACh3.0 imaging, and 575~630 nm filter was used for jRCaMP1a imaging. For odor stimulation, the odorant isoamyl acetate (Sigma-Aldrich, Cat#306967) was first diluted by 200-fold in mineral oil in a bottle and second diluted by 5-fold in air, which was then delivered to the fly's antenna at a rate of 1000 ml/min. For body shock, two wires were attached to the abdomen of the fly, and a 60~80 V electrical pulse were delivered for 500 ms during stimulation. For ACh application, a patch of blood-brain-barrier of the fly was carefully removed by tweezers before imaging, and the saline containing ACh was delivered to the brain to 20 mM final concentration. For optogenetic stimulation, the 635 nm laser (1 ms pulses at 10 Hz) were delivered through optical fibers placed near the fly brain. To implant EEG and EMG recording electrodes, mice were anesthetized with isoflurane (5% induction; 1.5 -2% maintenance) and placed on a stereotaxic frame with a heating pad. Two stainless steel screws for EEG were inserted into the skull above the visual cortex, two other screws were inserted into the skull above the frontal cortex, two insulated EMG electrodes were inserted into the neck muscle, and reference electrode was attached to a screw inserted into the skull above the cerebellum. The implant was secured to the skull with dental cement. All the experiments were carried out at least one week after the surgery. The EEG/EMG signals were recorded using TDT system-3 amplifiers (RZ2 + PZ5) with a high-pass filter at 0.5 Hz and digitized at 1500 Hz. Spectral analysis was carried out using fast Fourier transform (FFT) with a frequency resolution of 0.18 Hz. The brain states were scored every 5 seconds semi-automatically using a MATLAB GUI and validated manually by trained experimenters. Wakefulness was defined as desynchronized EEG and high EMG activity; NREM sleep was defined as synchronized EEG with high-amplitude delta activity (0.5 -4 Hz) and low EMG activity; REM sleep was defined as high power at theta frequencies (6 -9 Hz) and low EMG activity.
For ACh recording during foot-shock, mice were first habituated to the behavioral chamber set at 65db background noise and under infrared light for video visualization for 4 sessions (10 min per session, twice/day). Then, mice were habituated for 5 min before receiving foot-shock stimuli (10 trials of 0.2s or 1s long, 0.4 mA foot-shock intensity, 20s inter-trial intervals). Each foot-shock was coupled to the delivery of a 10ms long TTL output for synchronization with the fiber photometry recordings.
Two-photon imaging in mice.
To express ACh3.0, the mice were initially anesthetized with an injection of Avertin, the skin was retracted from the head, and a metal recording chamber was affixed. On the second day, the mice were anesthetized again, the skull above the visual cortex was opened, and ~500 nl of AAV was injected at the depth of 0.5 mm. A 4 mm x 4 mm square coverslip was used to replace the skull. Two-photon imaging in the visual cortex was performed 3 weeks after virus injection as previously reported 17 .
In brief, the mice were first attached with the baseplate and allowed to habituate for 2-3 days before the experiment. During the experiment, the miniature two-photon microscope was placed on the baseplate, and the mice were head-fixed on a treadmill controlled by an electric motor. The output trigger from the computer was used to synchronize the imaging with the treadmill. The speed of the treadmill was adjusted by the motor and was calibrated. Visual and auditory stimuli were generated using MATLAB. The visual stimulation was delivered to the mice by a video screen placed ~30 cm from the contralateral eye relative to the virus-expressing hemisphere. The visual and auditory stimuli were synchronized with the imaging using an Arduino board. Where indicated, drugs were injected i.p. 30 minutes before the experiment.
Immunohistochemistry and immunofluorescence. Immunohistochemistry was performed as previously described 20 . In brief, the mice were anesthetized, the heart was perfused, and the brain was extracted and post-fixed overnight in 4% paraformaldehyde. The fixed brains were then transferred into a PBS-azide solution, and a vibratome was used to cut 45-μm sections.
After slicing, free-floating sections were rinsed in washing buffer (PBS containing 0.15% Triton X-100), pre-incubated in 1% hydrogen for 30 minutes, and then rinsed in washing buffer. Sections were blocked for 1 h in washing buffer containing 5% (w/v) bovine serum albumin and 5% (v/v) normal goat serum. After blocking, the sections were incubated overnight in washing buffer containing the rabbit anti-VAChT antibody (Synaptic Systems, #139103; 1:250) plus 2% normal goat serum. After overnight incubation in primary antibody, the sections were rinsed in washing buffer and then incubated for 1 h in an anti-rabbit biotinylated antibody (Vector Laboratories, #ba-9400; 1:200) in washing buffer containing 2% normal goat serum. The sections were then rinsed in washing buffer and incubated with the VECTASTAIN ABC kit (Vector Laboratories) in accordance with the manufacturer's instructions. The substrate diaminobenzidine (Vector Laboratories) was added as a chromogen, and the sections where counterstained with 0.5% methyl green solution. The sections were then cleared in xylene and mounted on glass slides. For immunofluorescence, slices were prepared as described above and incubated in Tris-buffered saline (TBS) containing 1.2% Triton X-100 for 20 minutes. The sections were rinsed with TBS and blocked for 1 h in TBS containing 5% (v/v) normal goat serum. After blocking, the sections were rinsed twice with TBS, and then incubated for 24 h at 4°C with chicken anti-GFP (Abcam, #ab13970, 1:500) in TBS containing 0.2% Triton X-100 and 2% normal goat serum. After 24 hours, the sections were washed twice for 10 min each in TBS. The sections were then incubated for 1 h in Alexa 488 goat anti-chicken antibody (Life Technologies, #A11039; 1:500) in TBS containing 0.2% Triton X-100 and 2% normal goat serum. The sections were washed twice in TBS for 10 minutes, and then incubated in Hoechst 33342 (ThermoFischer, #H3570; 1:500) to counterstain the nuclei. The EVOS FL Auto 2 Cell Imaging System (Invitrogen) was used to visualize the sections.
Statistical analysis.
Except where indicated otherwise, all summary data are reported as the mean ± s.e.m. The signal-to-noise ratio (SNR) was calculated as the peak response divided by the standard deviation of the baseline fluorescence. Group differences were analyzed using the Student's t-test, and differences with a p-value <0.05 were considered significant. 
